Augmedix, Inc. (ticker: $AUGX) is set to be acquired by Commure, Inc. for $2.35 per share in cash, representing a 155.4% premium and valuing the transaction at approximately $139 million. The acquisition has attracted attention from Halper Sadeh LLC, which is investigating whether the sale is fair to shareholders. In related market activity, Morphic Holding, Inc. (ticker: $MORF) and Eli Lilly (ticker: $LLY) have launched a tender offer that will expire on August 15, while Ascendent Capital Partners is expected to close its deal with Holi (ticker: $HOLI) as soon as July 25. Additionally, VCICU has filed an S-1 registration statement for a $200 million offering. The market is seeing increased scrutiny on various transactions, with investigations initiated by Kahn Swick & Foti, LLC into several companies regarding the adequacy of their sales processes, including 23andMe (ticker: ME) and Chuy's Holdings (ticker: CHUY).